brain

April 27, 2026

Vanderbilt Health clinicians seek to improve care for those with traumatic brain injuries

CBIS training covers the cognitive, psychological and social consequences of brain injury; behavioral approaches for managing challenging behaviors and promoting positive skills; and techniques for effectively working with families of individuals with brain injury.

March 31, 2026

Memorial fund honors patient whose life was saved by Vanderbilt Health neurosurgeons  

Charlotte Davis’ family, grateful for Vanderbilt Health’s role in extending her life, has set up a fund in her memory to support neurosurgical research and patient care.  

June 2, 2025

Landmark bequest from Charlotte and Donald Test Jr. to advance psychiatry research

Named for Donald Test’s late sons, and Charlotte’s stepsons, the Henry and William Test Endowment Fund will bolster the Department of Psychiatry and Behavioral Sciences’ expansive research portfolio, promising a secure funding source for pathbreaking discoveries in areas such as schizophrenia, coordinated care models, brain imaging and neuromodulation.

Olivia Leow. (photo by Erin O. Smith)
January 15, 2025

Glioma Warriors — Alliance takes on brain cancer

Glioma is a cancer that afflicts people of all ages, including children. It is the deadliest pediatric cancer, and it’s also perplexing, evading the advances made in recent decades for other cancers.

January 15, 2025

Alzheimer’s study details abnormal gene expression tied to blood vessel growth

The study sets out how gene expression that drives the formation of new blood vessels exhibits different patterns, cell by cell, in the brains of people with Alzheimer’s disease.

Members of the Kang lab include (front row from left) Melissa Deleeuw, Jing-Qiong (Katty) Kang, MD, PhD, Wangzhen Shen, MD, and Karishma Randhave, and (back row from left) Ekta Anand, Debbie Song, and Kirill Zavalin, PhD. (photo by Susan Urmy)
December 10, 2024

Therapy for genetic epilepsy in children showing promise

Preliminary results of a clinical trial of 4-phenylbutyrate (PBA) “show a significant reduction in seizure activity among participants.”